The Northern New England Cardiovascular Disease Study Group: a regional collaborative effort for continuous quality

D J Malenka1, G T O'Connor

  • 1Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. david.malenka@hitchcock.org

The Joint Commission Journal on Quality Improvement
|November 5, 1998
PubMed

Insights

The Northern New England Cardiovascular Disease Study Group improved patient care through quality improvement initiatives and benchmarking. This led to a significant reduction in deaths following coronary artery bypass graft (CABG) surgery and percutaneous coronary interventions (PCI).

Area of Science:

  • Cardiovascular Surgery and Interventional Cardiology
  • Health Services Research
  • Quality Improvement Science

Background:

  • The Northern New England Cardiovascular Disease Study Group is a consortium of medical centers dedicated to improving patient care in cardiovascular surgery.
  • Established in 1987, the group comprises cardiothoracic surgeons, interventional cardiologists, and associated healthcare professionals.
  • The group focuses on coronary artery bypass graft (CABG) surgery and percutaneous coronary interventions (PCI).

Purpose of the Study:

  • To foster improvements in patient care through collaborative efforts and continuous quality improvement.
  • To monitor outcomes, train professionals, and benchmark practices among member institutions.
  • To identify causes and correlates of postoperative mortality and improve outcomes.

Main Methods:

  • Continuous monitoring of patient outcomes and performance metrics.
  • Implementation of quality improvement training and benchmarking initiatives.
  • Formation of study groups to examine specific issues, such as low-output states post-surgery.

Main Results:

  • Significant reduction in mortality following interventions, with 293 fewer deaths observed post-intervention compared to expected.
  • Improvements in hospital outcomes linked to advancements in technology, particularly coronary stenting.
  • Identified variability in practice patterns, such as stent usage, prompting further investigation.

Conclusions:

  • Observational studies are crucial for understanding actual clinical care and practice patterns.
  • Demonstrating variability in practice can stimulate research to answer critical clinical questions.
  • Collaborative quality improvement efforts can lead to substantial improvements in cardiovascular patient outcomes.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...